Christopher Peetz - Jul 23, 2024 Form 4 Insider Report for Mirum Pharmaceuticals, Inc. (MIRM)

Role
CHIEF EXECUTIVE OFFICER, Director
Signature
/s/ Judit Ryvkin, Attorney-in-Fact
Stock symbol
MIRM
Transactions as of
Jul 23, 2024
Transactions value $
$99,862
Form type
4
Date filed
7/24/2024, 05:32 PM
Previous filing
May 20, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction MIRM Common Stock Options Exercise $99.9K +34K +36.66% $2.94* 127K Jul 23, 2024 Direct
holding MIRM Common Stock 209K Jul 23, 2024 By The Peetz Family Trust

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction MIRM Stock Option (right to buy) Options Exercise $0 -34K -10.88% $0.00 278K Jul 23, 2024 Common Stock 34K $2.94 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 1/4th of the shares vested one year after November 5, 2018, and the balance of the shares vested in a series of 36 successive equal monthly installments at the end of each month thereafter.